Wellferon

ary human, Recombinant human interferon alpha-2, Recombinant human interferon d/in dry (Rekolin), Reaferon, Reaferon-EC. Wellferon is a drug that contains recombinant human interferon alpha and is used as an antiviral agent.

Wellferon is manufactured by Glaxo Wellcome in the UK. The drug is available in the form of an injection solution with different concentrations - 3000000 IU/ml and 10000000 IU/ml.

Wellferon is indicated for the treatment of a number of diseases, including hairy cell leukemia, chronic myeloid leukemia, viral hepatitis B and C, primary and secondary thrombocytosis, transitional form of chronic granulocytic leukemia and myelofibrosis, multiple myeloma, kidney cancer, as well as for the prevention and treatment of influenza and acute respiratory viral infection infections.

Before starting treatment with Wellferon, it is necessary to take into account contraindications to the use of the drug, such as hypersensitivity, severe heart disease, acute myocardial infarction, severe dysfunction of the liver, kidneys or hematopoietic system, epilepsy and/or other disorders of the central nervous system. The drug is not recommended for use in chronic hepatitis against the background of decompensated cirrhosis, as well as in chronic hepatitis in patients receiving or recently receiving immunosuppressant therapy (with the exception of short-term preliminary treatment with steroids). Also, restrictions on the use of Wellferon apply to pregnant and lactating women, as well as children.

Wellferon may cause some side effects, such as lethargy, fever, chills, loss of appetite, muscle pain, headache, joint pain, sweating, nausea, vomiting, changes in taste, dry mouth, weight loss, diarrhea, pain in abdomen, constipation, flatulence, increased peristalsis, heartburn, liver dysfunction, hepatitis, dizziness, visual disturbances, ischemic retinopathy, depression, drowsiness, impaired consciousness, nervousness, sleep disturbance and allergic skin reactions (rash, itching).

Wellferon's interaction with other drugs may interfere with the effectiveness of treatment or increase the risk of side effects. Therefore, before starting treatment, you must inform your doctor about all medications you are taking, including over-the-counter medications, as well as the presence of any chronic diseases.

There are also some features of the use of Wellferon in patients with certain diseases. For example, when treating hepatitis B and C, the drug can cause deterioration in thyroid function, so it is necessary to monitor the level of thyroid hormones and, if necessary, adjust the dosage of Wellferon. Also, when treating hepatitis C, the drug is used in combination with other antiviral drugs, which may increase the risk of side effects.

In general, Wellferon is an effective drug for the treatment of various diseases, including viral infections and cancer. However, before starting treatment, it is necessary to carefully evaluate the indications and contraindications, and discuss possible risks and side effects with your doctor.